Q1 revenue and EBITDA were up respectively by 64% and 66%, bang in line with our expectations.
We maintain our Buy on the stock. In early March the UK’s Competition and Markets Authority approved the acquisition of Hutchison’s 6k sites, subject to the divestment of around 1k of Cellnex’s existing UK sites. This was a surprising piece of good news and the stock has begun to recover (having decreased by 35% since last Summer) despite the war in Ukraine.
29 Apr 2022
Margin still progressing in Q1
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Margin still progressing in Q1
- Published:
29 Apr 2022 -
Author:
Jean-Michel Salvador -
Pages:
2
Q1 revenue and EBITDA were up respectively by 64% and 66%, bang in line with our expectations.
We maintain our Buy on the stock. In early March the UK’s Competition and Markets Authority approved the acquisition of Hutchison’s 6k sites, subject to the divestment of around 1k of Cellnex’s existing UK sites. This was a surprising piece of good news and the stock has begun to recover (having decreased by 35% since last Summer) despite the war in Ukraine.